Bearish flow noted in BridgeBio Pharma with 1,954 puts trading, or 1.7x expected. Most active are Aug-23 30 puts and Sep-23 25 puts, with total volume in those strikes near 1,600 contracts. The Put/Call Ratio is 1.77, while ATM IV is up nearly 5 points on the day. Earnings are expected on November 2nd.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BBIO:
- BridgeBio price target raised to $60 from $50 at Mizuho
- BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- BridgeBio reports inducement grants under Nasdaq listing rule
- BridgeBio Pharma Reports Second Quarter 2023 Financial Results and Business Update
- BridgeBio sees cash runway into 2H24